The experience of the International Consortium on Acute Promyelocytic Leukemia in monitoring minimal residual disease in acute promyelocytic leukaemia

Ana P. Lange, Ana S. Lima, Antonio R. Lucena-Araujo, Rafael H. Jácomo, Raul A. Melo, Rosane I. Bittencourt, Ricardo Pasquini, Katia Pagnano, Evandro M. Fagundes, Maria L. Chauffaille, Carlos S. Chiattone, Miguel A. Sanz, Francesco Lo-Coco, David Grimwade, Eduardo M. Rego

Research output: Contribution to journalArticle

Original languageEnglish
JournalBritish Journal of Haematology
DOIs
Publication statusAccepted/In press - 2016

Keywords

  • Acute leukaemia
  • Acute promyelocytic leukaemia
  • Minimal residual disease
  • PML/RARA
  • Quantitative PCR

ASJC Scopus subject areas

  • Hematology

Cite this

Lange, A. P., Lima, A. S., Lucena-Araujo, A. R., Jácomo, R. H., Melo, R. A., Bittencourt, R. I., Pasquini, R., Pagnano, K., Fagundes, E. M., Chauffaille, M. L., Chiattone, C. S., Sanz, M. A., Lo-Coco, F., Grimwade, D., & Rego, E. M. (Accepted/In press). The experience of the International Consortium on Acute Promyelocytic Leukemia in monitoring minimal residual disease in acute promyelocytic leukaemia. British Journal of Haematology. https://doi.org/10.1111/bjh.14490